| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |